+499.5%
MRNA vs BNS
+50.5%
+449.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BNS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.1% | -2.7% |
| 7D | +5.5% | +1.5% | +3.9% | +6.3% |
| 30D | +158.7% | +6.0% | +152.8% | +157.1% |
| 3M | +182.1% | +16.3% | +165.8% | +160.4% |
| 6M | +151.8% | +27.3% | +124.5% | +115.0% |
| YTD | +393.6% | +28.5% | +365.1% | +315.6% |
| 1Y | +499.5% | +49.0% | +450.5% | +309.2% |
| All | +499.5% | +50.5% | +449.0% | +309.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BNS.
Daily Out/Under-Performance
Portfolio return minus BNS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BNS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BNS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling